Peripheral Vascular Disease (PVD) Imaging Guidelines

Evicore's PVD Imaging Guidelines cover medically necessary vascular imaging (ABI/TBI, duplex US, CTA/MRA/CT, TEE, and select nuclear studies) for PAD, cerebrovascular disease, aortic aneurysms/dissections, venous disorders and post‑procedural surveillance, and explicitly exclude routine asymptomatic screening, obsolete nuclear/flow studies, experimental plaque morphology codes, and unjustified repeat studies. Approval requires a recent clinical evaluation (within 60 days) with focused vascular history/physical, documentation of prior tests (e.g., ABI within 60 days or exercise ABI/TBI when indicated), relevant labs (ESR/CRP for suspected vasculitis), modality‑specific clinical justification, and adherence to specified surveillance intervals.

"A pertinent clinical evaluation or meaningful technological contact is required prior to considering advanced imaging (telehealth, telephone, electronic messaging) including relevant medical treatm..."